WO2008020091A8 - Formulación farmacéutica para el tratamiento de afecciones - Google Patents
Formulación farmacéutica para el tratamiento de afecciones Download PDFInfo
- Publication number
- WO2008020091A8 WO2008020091A8 PCT/ES2006/000483 ES2006000483W WO2008020091A8 WO 2008020091 A8 WO2008020091 A8 WO 2008020091A8 ES 2006000483 W ES2006000483 W ES 2006000483W WO 2008020091 A8 WO2008020091 A8 WO 2008020091A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- pharmaceutical formulation
- complaints
- relates
- mainly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006800561118A CN101522198B (zh) | 2006-08-17 | 2006-08-22 | 用于治疗牛皮癣的药用制剂 |
MX2009001631A MX2009001631A (es) | 2006-08-17 | 2006-08-22 | Formulacion farmaceutica para el tratamiento de afecciones en la piel. |
AU2006347403A AU2006347403A1 (en) | 2006-08-17 | 2006-08-22 | Pharmaceutical formula for treating skin disease |
BRPI0621966-7A BRPI0621966A2 (pt) | 2006-08-17 | 2006-08-22 | formulaÇaÕ farmacÊutica para uso em tratamento de doenÇas de pele |
CA002661064A CA2661064A1 (en) | 2006-08-17 | 2006-08-22 | Pharmaceutical formula for treating skin disease |
IL197035A IL197035A0 (en) | 2006-08-17 | 2009-02-12 | Pharmaceutical formula for treating skin disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06380229.2 | 2006-08-17 | ||
EP06380229A EP1891960B1 (en) | 2006-08-17 | 2006-08-17 | Pharmaceutical formula for treating skin disease |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008020091A1 WO2008020091A1 (es) | 2008-02-21 |
WO2008020091A8 true WO2008020091A8 (es) | 2009-04-02 |
Family
ID=37499927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2006/000483 WO2008020091A1 (es) | 2006-08-17 | 2006-08-22 | Formulación farmacéutica para el tratamiento de afecciones |
Country Status (15)
Country | Link |
---|---|
US (1) | US7671044B2 (es) |
EP (1) | EP1891960B1 (es) |
CN (1) | CN101522198B (es) |
AT (1) | ATE444071T1 (es) |
AU (1) | AU2006347403A1 (es) |
BR (1) | BRPI0621966A2 (es) |
CA (1) | CA2661064A1 (es) |
DE (1) | DE602006009511D1 (es) |
DK (1) | DK1891960T3 (es) |
ES (1) | ES2334381T3 (es) |
IL (1) | IL197035A0 (es) |
MX (1) | MX2009001631A (es) |
PT (1) | PT1891960E (es) |
RU (1) | RU2432952C2 (es) |
WO (1) | WO2008020091A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2893979B2 (es) * | 2020-08-01 | 2023-02-21 | Mc Zosimo S L | Procedimiento para la obtención de una formulación para el tratamiento de dermatitis inflamatorias y producto obtenido |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0903344B1 (en) * | 1997-08-21 | 2011-01-26 | Shiseido Co., Ltd. | Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin |
AU3212099A (en) * | 1998-03-31 | 1999-10-18 | Johnson & Johnson Consumer Companies, Inc. | Method for increasing the permeability of horny human tissue |
ES2188426B1 (es) * | 2001-12-12 | 2004-11-16 | Rosalia Pidal Fernandez | Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias. |
KR20050096953A (ko) * | 2003-02-05 | 2005-10-06 | 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. | 물의 존재에 민감한 하나 이상의 활성제를 함유하는 반전에멀젼 유형 조성물, 및 미용 및 피부과에서의 그의 용도 |
WO2006051287A1 (en) * | 2004-11-10 | 2006-05-18 | Arrow International Limited | Composition and method for treatment of alopecia areata |
-
2006
- 2006-08-17 PT PT06380229T patent/PT1891960E/pt unknown
- 2006-08-17 AT AT06380229T patent/ATE444071T1/de active
- 2006-08-17 DE DE602006009511T patent/DE602006009511D1/de active Active
- 2006-08-17 EP EP06380229A patent/EP1891960B1/en not_active Not-in-force
- 2006-08-17 DK DK06380229.2T patent/DK1891960T3/da active
- 2006-08-17 ES ES06380229T patent/ES2334381T3/es active Active
- 2006-08-22 CN CN2006800561118A patent/CN101522198B/zh not_active Expired - Fee Related
- 2006-08-22 BR BRPI0621966-7A patent/BRPI0621966A2/pt not_active IP Right Cessation
- 2006-08-22 RU RU2009109356/15A patent/RU2432952C2/ru not_active IP Right Cessation
- 2006-08-22 WO PCT/ES2006/000483 patent/WO2008020091A1/es active Application Filing
- 2006-08-22 CA CA002661064A patent/CA2661064A1/en not_active Abandoned
- 2006-08-22 AU AU2006347403A patent/AU2006347403A1/en not_active Abandoned
- 2006-08-22 MX MX2009001631A patent/MX2009001631A/es active IP Right Grant
- 2006-09-14 US US11/521,073 patent/US7671044B2/en not_active Expired - Fee Related
-
2009
- 2009-02-12 IL IL197035A patent/IL197035A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2009109356A (ru) | 2010-09-27 |
PT1891960E (pt) | 2010-01-04 |
AU2006347403A1 (en) | 2008-02-21 |
US20080045487A1 (en) | 2008-02-21 |
DE602006009511D1 (de) | 2009-11-12 |
CA2661064A1 (en) | 2008-02-21 |
CN101522198A (zh) | 2009-09-02 |
EP1891960A1 (en) | 2008-02-27 |
MX2009001631A (es) | 2009-06-19 |
RU2432952C2 (ru) | 2011-11-10 |
IL197035A0 (en) | 2009-11-18 |
US7671044B2 (en) | 2010-03-02 |
WO2008020091A1 (es) | 2008-02-21 |
EP1891960B1 (en) | 2009-09-30 |
BRPI0621966A2 (pt) | 2011-12-27 |
ATE444071T1 (de) | 2009-10-15 |
ES2334381T3 (es) | 2010-03-09 |
CN101522198B (zh) | 2011-10-05 |
DK1891960T3 (da) | 2010-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY178634A (en) | Topical formulation for a jak inhibitor | |
WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
WO2006120682A3 (en) | Compositions and methods for treating hyperproliferative epidermal diseases | |
MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
IL178822A (en) | Amide @@ - @Phenylamino-Quinzoline-6-YL, medicinal preparations containing them, and their use in the preparation of drugs for the treatment of proliferative disorders | |
WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
WO2008006839A3 (en) | Combinations of flibanserin with caffeine, process for their preparation and use thereof as medicaments | |
NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
WO2005107810A3 (en) | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction | |
IL189270A (en) | Repamycins converted to phosphonate and their derivatives, pharmaceutical preparations containing them and their use in the prevention and treatment of bone and joint infections | |
PT1893237E (pt) | Composição farmacêutica compreendendo um elastómero organopolissiloxano e um princípio activo solubilizado | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
EP4241855A3 (en) | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | |
WO2008105088A1 (ja) | 脊髄損傷治療薬剤 | |
WO2008025830A3 (en) | Pharmaceutical and sunscreen compositions comprising caspase-14 | |
WO2009088673A3 (en) | Pharmaceutical composition | |
EP1741430A4 (en) | REMEDY FOR PSYCHO NEUROSIS DISEASES | |
ES2325291A1 (es) | "uso de un extracto de silybum marianum" | |
HK1111924A1 (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient | |
WO2008020091A8 (es) | Formulación farmacéutica para el tratamiento de afecciones | |
WO2009101497A3 (en) | Topical pharmaceutical combination comprising minoxidil and aminexil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680056111.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06807928 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 197035 Country of ref document: IL Ref document number: MX/A/2009/001631 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 609/KOLNP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2661064 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006347403 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2009109356 Country of ref document: RU Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06807928 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: PI0621966 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090217 |